PharmAla Biotech Holdings, Inc. Financial Overview
PharmAla Biotech Holdings, Inc.'s market cap is currently C$11.43M. The company's EPS TTM is C$; its P/E ratio is -5.22; PharmAla Biotech Holdings, Inc. is scheduled to report earnings on December 24, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.